BDI biotech reports a bidirectional insomnia–microbiome link
The study of over 400,000 people shows certain microbes increase insomnia risk while insomnia alters gut bacteria, suggesting microbiome-targeted therapies.
See the latest news and media coverage for BDI biotech. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biotechnology R&D and contract manufacturing services
bdibiotech.comLast updated
The study of over 400,000 people shows certain microbes increase insomnia risk while insomnia alters gut bacteria, suggesting microbiome-targeted therapies.
It complements renewed ISO 9001 and establishes EMS measures, resource monitoring, staff training, and objectives to reduce environmental impact.
It participates in an 8‑partner, 10‑researcher consortium developing cultured meat to prevent colon cancer and dyslipidemias and was top‑ranked in CDTI’s MISIONES call.
The project, approved by CDTI, studies ingredients to prevent colon cancer and dyslipidemias in meat products.
/PRNewswire-PRWeb/ -- BDI (Bridge Diagnostics, Inc.), a national leader in structural monitoring, instrumentation, and analysis, today announced its role as...
Currently the company has a new name: it is called Canvax Reagents. BDI Biotech is a group that offers the development of biotechnological processes, from...
The BDi biotechnology group (*BDi*), headquartered in Castilla y León has closed a capital increase of 1.9 million euros led by the...
Track BDI biotech and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to BDI biotech and other trending companies.